LIPIMETIX DEVELOPMENT, INC. (LDI) CONTINGENT VALUE RIGHTS AGREEMENT ISSUED BY CAPSTONE THERAPEUTICS CORP.Contingent Value Rights Agreement • August 27th, 2019 • Delaware
Contract Type FiledAugust 27th, 2019 JurisdictionTHIS LDI CONTINGENT VALUE RIGHTS AGREEMENT, (this “Agreement”) dated as of August 23, 2019 (the “Effective Date”), is entered into by and among Capstone Therapeutics Corp., a Delaware corporation (the “Company”), Computershare Inc. (“Computershare”) and its wholly owned subsidiary, Computershare Trust Company, N.A. together as rights agent (the “Rights Agent”) and the Shareholder Representative.
LIPIMETIX DEVELOPMENT, INC. (LDI) CONTINGENT VALUE RIGHTS AGREEMENT ISSUED BY CAPSTONE THERAPEUTICS CORP. BY AND AMONG CAPSTONE THERAPEUTICS CORP. THE SHAREHOLDER REPRESENTATIVE, AS DEFINED HEREIN AND COMPUTERSHARE INC. AND COMPUTERSHARE TRUST...Contingent Value Rights Agreement • August 26th, 2019 • Capstone Therapeutics Corp. • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 26th, 2019 Company Industry JurisdictionTHIS LDI CONTINGENT VALUE RIGHTS AGREEMENT, (this “Agreement”) dated as of August 23, 2019 (the “Effective Date”), is entered into by and among Capstone Therapeutics Corp., a Delaware corporation (the “Company”), Computershare Inc. (“Computershare”) and its wholly owned subsidiary, Computershare Trust Company, N.A. together as rights agent (the “Rights Agent”) and the Shareholder Representative.